Clinical Topics

How Does Breast Density Affect Cancer Risk, Tumor Type?

by U.S. Medicine

March 25, 2019

GAINESVILLE, FL—What is the association of mammographic breast density with breast cancer risk by tumor aggressiveness and by menopausal status and current postmenopausal hormone therapy?

That question was addressed in an article in Breast Cancer Research and Treatment. Led by University of Florida-led researchers and including participation from the San Francisco VA Healthcare System, the study included 2,596 invasive breast cancer cases and 4,059 controls selected from participants of four nested case-control studies within four established cohorts: the Mayo Mammography Health Study, the Nurses’ Health Study, Nurses’ Health Study II, and San Francisco Mammography Registry.1

Researchers assessed percent breast density, absolute dense and non-dense areas from digitized film-screen mammograms using a computer-assisted threshold technique and standardized across studies.

Results indicated that, overall, the positive association of PD and borderline inverse association of NDA with breast cancer risk was stronger in aggressive vs. non-aggressive tumors (≥51 vs. 11-25% OR 2.50, 95% CI 1.94-3.22 vs. OR 2.03, 95% CI 1.70-2.43, p-heterogeneity = 0.03; NDA 4th vs. 2nd quartile OR 0.54, 95% CI 0.41-0.70 vs. OR 0.71, 95% CI 0.59-0.85, p-heterogeneity = 0.07).

“However, there were no differences in the association of DA with breast cancer by aggressive status,” researchers wrote, adding, “In the stratified analysis, there was also evidence of a stronger association of PD and NDA with aggressive tumors among postmenopausal women and, in particular, current estrogen+progesterone users (≥51 vs. 11-25% OR 3.24, 95% CI 1.75-6.00 vs. OR 1.93, 95% CI 1.25-2.98, p-heterogeneity = 0.01; NDA 4th vs. 2nd quartile OR 0.43, 95% CI 0.21-0.85 vs. OR 0.56, 95% CI 0.35-0.89, p-heterogeneity = 0.01), even though the interaction was not significant.”

The study team said their findings suggest that associations of mammographic density with breast cancer risk differ by tumor aggressiveness. “While there was no strong evidence that these associations differed by menopausal status or hormone therapy, they did appear more prominent among current estrogen+progesterone users,” the authors explained.

1. Yaghjyan L, Tamimi RM, Bertrand KA, Scott CG, et. Al. Interaction of mammographic breast density with menopausal status and postmenopausal hormone use in relation to the risk of  aggressive breast cancer subtypes. Breast Cancer Res Treat. 2017 Sep;165(2):421-431. doi: 10.1007/s10549-017-4341-2. Epub 2017 Jun 17. PubMed PMID: 28624977; PubMed Central PMCID: PMC5773252.


Comments are closed here.


Related Articles

VA Facing Critical Healthcare Staffing Shortages in Near Future

Replacing Retirees Hampered by Lower Salaries WASHINGTON—Oversight agencies are sounding the alarm that VA is plagued with large staffing shortages in critical areas, including physicians, registered nurses, physician assistants, psychologists and physical therapists, as well... View Article

Army Conducts First-in-Human Trial of MERS Coronavirus Vaccine

SILVER SPRING, MD—Middle East respiratory syndrome emerged first in Saudi Arabia in 2012 before spreading to several other countries, including a major outbreak in South Korea. In total, the MERS coronavirus infected more than 2,200... View Article


U.S. Medicine Recommends


More From breast cancer

Breast Cancer

Surgery Delay Does Not Explain Racial Differences in Breast Cancer Survival

BETHESDA, MD—Black women die from breast cancer at a higher rate than white women, but exactly why remains unclear. A new study from the Military Health System just shot down one of the leading explanations... View Article

Breast Cancer

Chemotherapy Use Declines for Breast Cancer Patients

With growing concern about overtreatment of breast cancer as outcomes have improved over time, not much research has been performed on how chemotherapy use and oncologists' recommendations have changed in recent years.

Breast Cancer

Breast Cancer Surgery Increasing at VA

Women will make up approximately 10% of the VA healthcare system by 2020 and 15% by 2030, meaning that the need for women’s health services, including breast cancer treatment, will increase.

Breast Cancer

No Higher Breast Cancer Rates Among Transgender Veterans

JOHNSON CITY, TN – Consistent with past European studies, new research from the Mountain Home VAMC suggests that transgender (TG) veterans have no higher rates of breast cancer than others. The study, published recently in... View Article

Breast Cancer

Biology Blamed for Later-Stage Breast Cancer in Black Women

SAN DIEGO – African-American women present with more aggressive breast tumors and at later stages than white women. Many factors have been proposed to explain these findings, including socioeconomic status, cultural beliefs and access to... View Article

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up